Brad Middlekauff, J.D.

Brad Middlekauff, J.D.

Chief Legal Officer

Brad Middlekauff is the Chief Legal Officer of Castle Creek Biosciences, Inc. A respected life sciences executive with more than 25 years of experience in the biotechnology industry, Mr. Middlekauff previously served as General Counsel of Immunovant, Inc., which he took public through a special purpose acquisition company (SPAC) in 2019. 

Prior to joining Immunovant, Mr. Middlekauff was Senior Vice President, General Counsel and Secretary of PDS Biotechnology Corporation (formerly known as Edge Therapeutics), a publicly-traded life sciences company. Before Edge, Mr. Middlekauff served as Executive-in-Residence at Princeton University. Previously, he was Chief Legal Officer, General Counsel and Secretary at Kolltan Pharmaceuticals, Inc., where he also led business development; Senior Vice President, General Counsel and Secretary of Medarex, Inc.; and Vice President, Business Development and General Counsel at Algos Pharmaceuticals. Following law school and a clerkship in the Southern District of New York, Mr. Middlekauff started his legal career at Cooley Godward, where he advised life science companies on a broad range of business and legal matters.

Mr. Middlekauff was a finalist in the 2018 New Jersey General Counsel of the Year awards. He has served as Chairman of the Biotechnology Industry Organization (BIO) General Counsels’ Committee and Vice President of the Yale Law School Executive Committee. Mr. Middlekauff has presented at numerous conferences on legal and business issues relating to biotechnology.

He earned his B.A. in political science from Brown University and his J.D. from Yale Law School.